Cost-effectiveness of nutritional supplementation and exercise programme among older people in Santiago, Chile

Completed

Conditions: Pneumonia and physical functional decline
Respiratory
Pneumonia and functional ability

Registration Number: ISRCTN48153354

Lead Sponsor: ondon School of Hygiene and Tropical Medicine (UK)

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Completed

Sex: All

Target Recruitment: 2800

Inclusion Criteria

1. Aged 65.0 to 67.9 at baseline
2. Living in the catchment area of one of 28 selected health centres of low/medium socio-economic status in Santiago, Chile

Exclusion Criteria

1. Non-ambulatory
2. Recent un-explained weight loss (more than 3 kg in past three months)
3. Possible clinical dementia (as assessed via mini-mental state examination)

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Current information as of 22/09/2010:<br>1. For nutrition intervention: <br>The incidence of pneumonia over the 24 months after the initiation of the intervention. <br>2. For exercise intervention: <br>Walking capacity (distance walked in six minutes) 24 months after initiation of the intervention. <br><br>Initial information at time of registration:<br>1. Incidence of pneumonia over 24 months of intervention and subsequent six months<br>2. Change in walking capacity over 24 months of intervention<br>3. Change in body mass index over 24 months of intervention

Secondary Outcome Measures

Name	Time	Method
Added 22/09/2010<br>1. Body mass index <br>2. Incidence of acute respiratory infection <br>3. Self-reported health status (Short-Form 36) <br>4. Depression, assessed bt Geriatric Depression Scale (GDS-15) <br>5. Self-reported incidence of chronic diseases <br>6. Physical and functional limitations <br>7. Self reported productive activity <br>8. Self-reported incidence of falls <br>9. Self-reported incidence of fracture <br>10. Blood pressure <br>11. Anthropometry <br>12. Timed up-and-go assessment <br>13. Blood indicators of cardiovascular disease risk and insulin resistance (in a sub-sample)